Radiopharmaceuticals Market Strategic Insights and key Business Influencing Factors | Major Players – Advanced Accelerator Applications, Surgery Theater, Positron Corporation, NTP, IsoPET, Eli Lilly and Company.
Radiopharmaceuticals Marketare a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy. The procedures and facilities for the production, use, and storage of radiopharmaceuticals are subject to licensing by national or regional authorities. This licensing includes compliance both with governing radioactive materials and with those regulations governing pharmaceutical preparations. Additional regulations may apply for issues such as transportation or dispensing of radiopharmaceuticals.
The global radiopharmaceuticals market is expected to rise to an estimated value of USD 11.85 billion by 2026 registering a substantial CAGR of 9.30% in the forecast period of 2019-2026. In the rise in market can be attributed to increasing prevalence of cancer and cardiovascular chronic diseases, rising health expenditure and technological advancements.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market
Competitive Analysis: Global Radiopharmaceuticals Market
Few of the major competitors currently working in Global Radiopharmaceuticals Market are Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion (Canada) Inc., Advanced Accelerator Applications, Surgery Theater, Positron Corporation, NTP, IsoPET, Eli Lilly and Company., Jubilant Pharma. LLC, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Areva Pharma, Merck & Co., Inc., Navidea Biopharmaceuticals, Inc., Eckert & Ziegler., Siemens Healthcare Private Limited, Novartis AG, Curium, among others..
Key Pointers Covered in the Global Radiopharmaceuticals Market Trends and Forecast to 2026
- Global Radiopharmaceuticals Market New Sales Volumes
- Global Radiopharmaceuticals Market Replacement Sales Volumes
- Global Radiopharmaceuticals Market Installed Base
- Global Radiopharmaceuticals Market By Brands
- Global Radiopharmaceuticals Market Size
- Global Radiopharmaceuticals Market Procedure Volumes
- Global Radiopharmaceuticals Market Product Price Analysis
- Global Radiopharmaceuticals Market Healthcare Outcomes
- Global Radiopharmaceuticals Market Cost of Care Analysis
- Global Radiopharmaceuticals Market Regulatory Framework and Changes
- Global Radiopharmaceuticals Market Prices and Reimbursement Analysis
- Global Radiopharmaceuticals Market Shares in Different Regions
- Recent Developments for Global Radiopharmaceuticals Market Competitors
- Global Radiopharmaceuticals Market Upcoming Applications
- Global Radiopharmaceuticals Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
Key Developments in the Market:
- In April 2018, Cyclopharma has entered into an agreement to sell all its radiopharmaceutical manufacturing and commercialization activities to Curium. With this acquisition, Curium would be able to expand its manufacturing, development and designs of new compounds, thereby expanding its radiopharmaceutical business to soon become a world leader
- In January 2018, Advanced Accelerator Application (AAA) received the permission from USA’s FDA to use Lutathera for treating a type of cancer which affects pancreas/ gastrointestinal tract i.e. Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This is the very first time approval has been given to use a radiopharmaceutical for treating GEP-NETs. Thus, with this approval, radiopharmaceuticals have now been approved to treat a whole new disease, thereby expanding its market, which would significantly contribute towards the growth of radiopharmaceuticals market globally in the forecasted period
Segmentation: Global Radiopharmaceuticals Market
- Global Radiopharmaceuticals Market By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Application (Diagnostic, Therapeutic), Procedural Volumes (Diagnostic Procedures, Therapeutic Procedures), Source (Nuclear Reactors, Cyclotrons), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026
Inquire Before Buying:
Key insights in the report:
- Complete and distinct analysis of the market drivers and restraints
- Key Market players involved in this industry
- Detailed analysis of the Market Segmentation
- Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here: